C. Wellens

发表

Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma

P. Meltzer, P. Pollock, J. Trent, 2009, Molecular Cancer Research.

Inhibition of activated FGFR2 in endometrial cancer cells induces cell death despite PTEN abrogation

P. Pollock, S. Byron, P. Goodfellow, 2012 .

LOSS-OF-FUNCTION FGFR2 MUTATIONS IN MELANOMA

P. Meltzer, J. Trent, S. Byron, 2017 .

LOSS-OF-FUNCTION FGFR 2 MUTATIONS IN MELANOMA

P. Meltzer, J. Trent, S. Byron, 2012 .

FGFR2Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features

P. Pollock, S. Byron, F. Gao, 2012 .

Plant based HIV-1 vaccine candidate: Tat protein produced in spinach.

M. Reitz, H. Koprowski, D. Hone, 2005, Vaccine.

Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.

Matthew A Powell, Sara A Byron, Candice L Wellens, 2008, Cancer research.

FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features

P. Pollock, S. Byron, P. Goodfellow, 2012, PloS one.

Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status

John Wang, Sara A Byron, David C Loch, 2012, Molecular Cancer.

FGFR2 mutations are rare across histologic subtypes of ovarian cancer.

P. Pollock, S. Byron, P. Goodfellow, 2010, Gynecologic oncology.

Correction: FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features

P. Pollock, S. Byron, P. Goodfellow, 2012, PLoS ONE.